Mandate

Vinge Advises Fagerberg & Dellby Fond I AB

May 19, 2008

Ulrika Dellby and Christina Fagerberg was assistance by Vinge in the start-up of a venture capital fund. The fund has raised SEK 320 million. The principal purpose of the fund will be to acquire Swedish companies.

- Ulrika Dellby and Christina Fagerberg have managed to set up a fund when the conditions for doing so have not been opportune, the climate for fundraising has not been particularly favourable, but they have succeeded, says Vinge partner Mattias Schömer, who gave Ulrika Dellby and Christina Fagerberg legal advice.   

In the venture capital industry a buy-out fund acquires developed companies with a stable cash flow. Dellby and Fagerberg will focus on family-owned companies in which the owner wants to remain in the company. Advisors to the fund will, among others, be: Ulf Spendrup, Bo Johnson, Lars Fredriksson and Monica Caneman.

Vinge’s team was made up of Mattias Schömer, Pontus Enquist, Maria Doeser, Joacim Rydergård and Mari Hansson. 
 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026